Children with SJIA complicated by MAS respond better to anakinra treatment rather than anti-TNF therapy indicating the critical importance of IL-1 family cytokines in driving MAS [39]. This evidence concerns the gene IL1A and systemic-onset juvenile idiopathic arthritis.